Testimony before Investigations and Oversight Committee, Committee on Science and Technology, U.S. House of Representatives, April 27, 1983

by Richard A. Rettig

Purchase Print Copy

 FormatList Price Price
Add to Cart Paperback6 pages $20.00 $16.00 20% Web Discount

Discusses some of the author's views on kidney transplantation and organ procurement based on his RAND studies. In particular, he recommends attention be made to the following: set reasonable objectives for the number of kidney transplant procedures; recognize the complex nature of cost savings due to improved kidney transplantation; and improve organ procurement. The last section of the paper deals with policy implications of new policies in kidney transplantation.

This report is part of the RAND Corporation paper series. The paper was a product of the RAND Corporation from 1948 to 2003 that captured speeches, memorials, and derivative research, usually prepared on authors' own time and meant to be the scholarly or scientific contribution of individual authors to their professional fields. Papers were less formal than reports and did not require rigorous peer review.

The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.